Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX)

CUSIP: 45720N103

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-220,946
Put/Call ratio
4.2%
SEC-reported price per share
$67.23
Number of holders
134
Value change
-$23,513,581
Number of buys
71
Open additional details 1 more signal available
Number of sells
60
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,630,961

Security key

45720N103

Report period

Q1 2026

Institutions

134

Top holders

10

Ownership snapshot

Top reported holders of INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F 13D/G 3/4/5 Lead comparable stake: 10% 13D/G row: PERCEPTIVE ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
PERCEPTIVE ADVISORS LLC 10%
VIKING GLOBAL INVESTORS LP 10%
MORGAN STANLEY 7.9%
Jon Faiz Kayyem 7.9%
Mark P. Lappe 6.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F 13D/G
Company
10%
from 13D/G
$114,763,853
1,452,707 shares
31 Dec 2025
VIKING GLOBAL INVESTORS LP
13F 13D/G 3/4/5
Company · 10%+ Owner
10%
from 13D/G
$113,578,695
1,437,705 shares
31 Dec 2025
MORGAN STANLEY
13F 13D/G
Company
7.9%
from 13D/G
$92,250,538
1,167,728 shares
31 Dec 2025
Jon Faiz Kayyem
13D/G
7.9%
$13,765,571
1,149,046 shares
$0 03 Jun 2024
Mark P. Lappe
3/4/5 13D/G
Chief Executive Officer, Director · Mark Lappe
6.4%
from 13D/G
$15,852,324
1,225,413 shares
mixed-class rows
12 Sep 2024
BlackRock, Inc.
13F 13D/G
Company
5.3%
from 13D/G
$61,413,257
777,383 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
134
Shares
12,713,962
Rows available
134
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
139
Q1 2026 holders
134
Holder diff
-5
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .